Although a body of literature suggests that a small percentage of diffuse astrocytomas, WHO grade II, have BRAF structural rearrangements, the progression to high-grade gliomas that is expected in diffuse astrocytomas is not expected in tumors with BRAF fusions [24]. The gene discussed is BRAF; the disease is diffuse astrocytoma.